Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers

British Journal of Cancer

Volumn 109, Issue 5, 2013, Pages 1279-1286

  Xu, B ^a   Gao, L ^b   Wang, L ^a   Tang, G ^a   He, M ^a   Yu, Y ^a   Ni, X ^b   Sun, Y ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

platelet activating factor; prostate cancer; androgen; LPCAT1

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; ACYLTRANSFERASE; ANDROGEN RECEPTOR ANTAGONIST; ANDROSTANOLONE; BETA CATENIN; LYSO PLATELET ACTIVATING FACTOR ACETYL TRANSFERASE; PLATELET ACTIVATING FACTOR SYNTHETASE; STEROID HORMONE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CASTRATION RESISTANT PROSTATE CANCER; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN LNCAP; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE; ANDROGEN RECEPTOR ANTAGONISTS; ANDROGENS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLOFENIL; DIHYDROTESTOSTERONE; DISEASE PROGRESSION; ESTRADIOL; HORMONE ANTAGONISTS; HUMANS; IMIDAZOLES; INDOLES; MALE; MIFEPRISTONE; PLATELET ACTIVATING FACTOR; PROSTATIC NEOPLASMS; PROTEIN KINASE INHIBITORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; WNT PROTEINS;

EID: 84883739724     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.480     Document Type: Article

References (31)

1. Axelrad TW, Deo DD, Ottino P, Van Kirk J, Bazan NG, Bazan HE, Hunt JD (2004) Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J 18(3): 568-570.
2. Bussolati B, Biancone L, Cassoni P, Russo S, Rola-Pleszczynski M, Montrucchio G, Camussi G (2000) PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol 157(5): 1713-1725.
3. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman Jr OB, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI. COU-AA-301 Investigators (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364(21): 1995-2005.
4. Dreicer R, Gleave M, Kibel AS, Thrasher JB, Moul JW (2011) Targeting the androgen receptor-theory and practice. Urology 78(5 Suppl): S482-S484.
5. Enayetallah AE, French RA, Grant DF (2006) Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms. J Mol Histol 37(3-4): 133-141.
6. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487(7406): 239-243.
7. Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C, Warner M, Gustafsson JA (2004) Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA 101(25): 9375-9380. (Pubitemid 38821066)
8. Jain S, Chakraborty G, Raja R, Kale S, Kundu GC (2008) Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res 68(19): 7750-7759.
9. Jan CR, Chao YY (2004) Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2\+ levels and growth of human prostate cancer cells. Cell Signal 16(8): 959-965.
10. Masiello D, Chen SY, Xu Y, Verhoeven MC, Choi E, Hollenberg AN, Balk SP (2004) Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells. Mol Endocrinol 18(10): 2388-4201.
11. McKiernan J, Benson MC (2004) Predicting the clinical course of prostate cancer. J Clin Invest 113(6): 806-808. (Pubitemid 38544137)
12. McPherson SJ, Ellem SJ, Risbridger GP (2008) Estrogen-regulated development and differentiation of the prostate. Differentiation 76(6): 660-760.
13. McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA, Risbridger GP (2010) Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated. Proc Natl Acad Sci USA 107(7): 3123-3128.
14. Muguruma K, Komatz Y, Ikeda M, Sugimoto T, Saito K (1993) Platelet-activating factor (PAF) in male reproductive organs of guinea pigs and rats: effect of androgen on PAF in seminal vesicles. Biol Reprod 48(2): 386-392. (Pubitemid 23024507)
15. Nie D, Guo Y, Yang D, Tang Y, Chen Y, Wang MT, Zacharek A, Qiao Y, Che M, Honn KV (2008) Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho. Cancer Res 68(1): 115-121. (Pubitemid 351380112)
16. Patel MI, Kurek C, Dong Q (2008) The arachidonic acid pathway and its role in prostate cancer development and progression. J Urol 179(5): 1668-1675.
17. Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME (2002) Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 277(23): 20702-20710. (Pubitemid 34967374)
18. Reis LO (2012) Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question. Endocr Relat Cancer 19(3): R93-R98.
19. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP (2008) Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 22(5): 1512-1520. (Pubitemid 351656791)
20. Sato SM, Johansen JA, Jordan CL, Wood RI (2010) Membrane androgen receptors may mediate androgen reinforcement. Psychoneuroendocrinology 35(7): 1063-1073.
21. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA, Tang J, Adami HO, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson SO, Varenhorst E, Johansson JE, Brown M, Golub TR, Rubin MA (2008) Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 100(11): 815-825. (Pubitemid 351809667)
22. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1): 10-29.
23. Song LN, Herrell R, Byers S, Shah S, Wilson EM, Gelmann EP (2003) Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol 23(5): 1674-1687. (Pubitemid 36246049)
24. Tong M, Tai HH (2000) Induction of NAD(\+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. Biochem Biophys Res Commun 276(1): 77-81.
25. Truica CI, Byers S, Gelmann EP (2000) Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60(17): 4709-4713.
26. Uotila P, Valve E, Martikainen P, Nevalainen M, Nurmi M, Härkönen P (2001) Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol Res 29(1): 23-28.
27. Wang LS, Chow KC, Wu YC (2002) Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. Scand J Gastroenterol 37(4): 467-475.
28. Weihua Z, Lathe R, Warner M, Gustafsson JA (2002) An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99(21): 13589-13594. (Pubitemid 35221316)
29. Xu B, Sun Y, Tang G, Xu C, Wang L, Zhang Y, Ji J (2009) Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor. Cancer Lett 278(2): 220-229.
30. Youlyouz I, Magnoux E, Guglielmi L, Denizot Y (2002) Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines. Mediators Inflamm 11(5): 329-331. (Pubitemid 35335225)
31. Yu J, Akishita M, Eto M, Koizumi H, Hashimoto R, Ogawa S, Tanaka K, Ouchi Y, Okabe T (2012) Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem Biophys Res Commun 424(3): 538-543.